No Prison Time For Former Olympus Exec In Scope Case
Executive Summary
A former Olympus exec who took personal responsibility for the company’s failure to submit duodenoscope-related adverse event reports has been sentenced to one year’s probation and a $5,000 fine.
You may also be interested in...
Continued Risks Of Duodenoscopes Leads FDA To Recommend Disposable Cap Devices
After a study earlier this year found that fixed endcap duodenoscopes continued to pose a significant risk of infecting patients after being washed, the US agency is now urging providers to switch to newer-designed scopes that reduce or eliminate the risk from reprocessing, such as duodenoscopes that have interchangeable caps. The directive from the FDA is good news for Boston Scientific, which makes a disposable duodenoscope that is close to being approved by the agency.
Adverse-Event Reporting Failure Leads To Guilty Plea For Olympus, Exec
Olympus Medical Systems and a former senior executive have pleaded guilty to allegations that they sold duodenoscopes even after failing to submit required adverse-event reports on them.
US FDA Report Confirms Duodenoscope Contamination Risk
An early look at the results of post-market studies that had been ordered by US FDA for duodenoscopes highlights ongoing sterilization issues.